Skip to main content
    E

    Evolent Health Inc (EVH)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $4.62
    -0.21 (-4.45%)

    Market Cap: $554.22M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Evolent Health Inc (EVH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Evolent Health (EVH) has a market cap of $554.22M and an enterprise value of $1.38B. Its net debt of $821.23M equals 148.18% of its market cap. It kept -21.67% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 148.18% above the market cap, as debt exceeds cash.

    Market Cap$554.22M
    Enterprise Value$1.38B
    Latest price (Nov 17, 2026)$4.62

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.47% in the quarter ended Sep 30, 2026 and shrank 0.78% a year over 2 years.

    Shares Outstanding113.07M
    Shares Change (YoY)-0.87%
    Shares Change (QoQ)+0.47%
    Share Count Growth (2Y CAGR)-0.78%

    Valuation Ratios

    Sales and book value multiples are 0.2x and 1.4x. Its year-end P/S ranged from 0.2x to 2.7x from 2016 to 2025.

    Forward P/E22.1x
    P/S Ratio0.2x
    Forward P/S0.2x
    P/B Ratio1.4x
    P/FCF Ratio14.2x
    P/OCF Ratio8.5x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 36.6x free cash flow.

    EV / Sales0.6x
    EV / FCF36.6x

    Price Statistics

    The stock is up 10.41% over 52 weeks and trades 8.96% above its 50-day average.

    Beta (1Y)1.02
    52-Week Change+10.41%
    1-Month Change+3.01%
    3-Month Change+0.76%
    6-Month Change+18.64%
    5-Year Change-85.31%
    10-Year Change-79.57%
    Total Return (1Y)+10.41%
    Total Return (3Y CAGR)-46.01%
    Total Return (5Y CAGR)-30.91%
    Return vs SPY (1Y)+3.82%
    Max Drawdown (1Y)-50.24%
    Max Drawdown (3Y)-93.75%
    Sharpe Ratio (1Y)0.19
    Correlation with SPY (1Y)0.18
    50-Day Average$4.24
    200-Day Average$3.93
    52-Week Range$2.10 to $6.25
    RSI (14 Days)51.4
    Average Volume (20 Days)1.70M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.26x current liabilities, and total debt is 2.60x shareholder equity.

    Current Ratio1.26x
    Quick Ratio1.26x
    Debt / Equity2.60x
    Debt / FCF26.45x
    Interest Coverage-5.90x

    Returns and Efficiency

    Return on invested capital is -32.37% over the last 12 months, against a 5-year average of -13.67%.

    Return on Equity (ROE)-136.17%
    Return on Assets (ROA)-25.87%
    Return on Invested Capital (ROIC)-32.37%
    Return on Capital Employed (ROCE)-29.52%
    ROE (5Y Average)-30.63%
    ROA (5Y Average)-7.70%
    ROIC (5Y Average)-13.67%
    Asset Turnover1.06x
    Receivables Turnover5.25x

    Scores

    EVH has an Altman Z-Score of -0.26, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-0.26
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $2.34B over the last 12 months is up 14.06% from the 12 months before.

    Revenue$2.34B
    Revenue Growth (YoY)+14.06%
    Gross Profit$350.28M
    Operating Income-$434.58M
    Pretax Income-$504.63M
    Net Income-$507.69M
    EBITDA-$308.82M
    EBIT-$434.58M
    Reported EPS (TTM)-$0.09

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 19.02% of the $1.96B in total assets.

    Cash and Equivalents$148.25M
    Total Debt$969.48M
    Net Debt$821.23M
    Net Debt Per Share$7.26
    Working Capital$127.18M
    Shareholder Equity$372.85M
    Book Value Per Share$3.30
    Tangible Book Value-$860.74M
    Total Assets$1.96B
    Total Liabilities$1.59B

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $28.23M of capital spending, operating cash flow left $36.66M of free cash flow.

    Operating Cash Flow$64.88M
    Capital Expenditures$28.23M
    Free Cash Flow$36.66M
    FCF Per Share$0.32
    Depreciation and Amortization$125.76M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -18.55%, against a 5-year average of -6.29%.

    Gross Margin14.95%
    Operating Margin-18.55%
    Pretax Margin-21.54%
    Net Margin-21.67%
    EBITDA Margin-13.18%
    EBIT Margin-18.55%
    FCF Margin1.56%
    Gross Margin (5Y Average)22.03%
    Operating Margin (5Y Average)-6.29%
    Net Margin (5Y Average)-8.44%

    Growth

    Revenue grew 11.54% a year over 3 years, and EPS fell 71.99% a year.

    Revenue Growth (3Y CAGR)+11.54%
    Revenue Growth (5Y CAGR)+15.20%
    EPS Growth (3Y CAGR)-71.99%
    Book Value Per Share Growth (2Y CAGR)-37.81%

    Revenue and profit by year

    Dividends and Yields

    EVH does not pay a dividend. Its free cash flow yield is 7.02%.

    FCF Yield7.02%
    Shareholder Yield0.00%

    Peer Position

    Against 11 similar companies, EVH has the lowest P/S.

    P/S Ratio0.2x vs 2.5x median
    ROIC-32.37% vs 2.72% median
    Revenue Growth (Trailing 4 Quarters, YoY)+14.06% vs +7.73% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 32.99% and EPS growth at 359.84% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+32.99%
    EPS Growth Forecast (2Y CAGR)+359.84%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About EVH

    What is EVH's market cap?

    Evolent Health has a market cap of $554.22M. Its enterprise value, which adds debt and subtracts cash, is $1.38B.

    How many shares of EVH are outstanding?

    Evolent Health has 113.07M shares outstanding. The count is down 0.87% from a year earlier.

    Does EVH pay a dividend?

    No. Evolent Health does not pay a dividend.

    How much debt does EVH have?

    Evolent Health has $969.48M of total debt and $148.25M of cash and equivalents, a net debt position of $821.23M.